Author

S. Prassl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Carle· 1 shared C. Paulmann· 1 shared C. Reitinger· 1 shared E. Bluemle· 1 shared F. Nimmerjahn· 1 shared K. Beckmann· 1 shared L. Kazandijan· 1 shared N. Jurkschat· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Carle

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Fcgamma-receptor-independent controlled activation of CD40 canonical signaling by novel therpeutic antibodies for cancer therapy

C. Reitinger, K. Beckmann, A. Carle, E. Bluemle, N. Jurkschat, C. Paulmann, S. Prassl, L. Kazandijan, F. Nimmerjahn, S. Fischer

Novel Fc-silenced anti-CD40 antibodies activate antigen-presenting cells and humanized mice without Fcγ-receptor dependence, showing efficacy and reduced toxicity compared to existing therapies.

bioRxiv · Jan 16, 2023 · PreprintImmunology